EDITAS MEDICINE, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $13.7M | $4.3M | $785.0K | $0 |
| Collaboration Revenue | $13.7M | $4.3M | $785.0K | $0 |
| License Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $83.2M | $57.0M | $18.8M | $5.1M |
| SG&A Expense | $50.5M | $46.3M | $18.1M | $7.7M |
| Operating Income | $-119.9M | $-97.2M | $-35.3M | $-12.7M |
| Operating Margin | -875.0% | -2,261.2% | -4,498.3% | — |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | $-120.3M | $-97.2M | $-72.9M | $-13.7M |
| Net Margin | -877.8% | -2,261.1% | -9,286.6% | — |
| EPS (Basic) | $-2.98 | $-3.02 | $-28.55 | $-12.46 |
| EPS (Diluted) | $-2.98 | $-3.02 | $-28.55 | $-12.46 |
| Shares Outstanding (Basic) | 44.5M | 35.8M | 3.2M | — |
| Shares Outstanding (Diluted) | 44.5M | 35.8M | 3.2M | — |
| Dividends Per Share | — | — | — | — |